Dose-response Association Between hsCAR and MAFLD: A Cross-sectional Study
Conditions: Metabolic Dysfunction-associated Fatty Liver Disease; Hepatic Steatosis; Liver Fibrosis Intervention: Other: high-sensitivity C-reactive protein to albumin ratio Sponsor: Chongqing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Fatty Liver Disease (FLD) | Liver | Liver Disease | Research | Study | Urology & Nephrology